SIRT1 reduction also correlated with neuroinflammation: increased inflammatory molecule levels (e.g., interleukins and chemokines) have been detected in the brain of AD patients in the earlier phases of the disease, precisely when SIRT1 levels begin to shrink [34]. The gene discussed is SIRT1; the disease is Alzheimer disease.